Cambridge biotech VC firm Clarus acquired by Blackstone
October 04, 2018 at 15:00 PM EDT
Clarus is known for partnering with drugmakers like Pfizer, AstraZeneca and Eisai to fund Phase 3 drug trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|